UK Interdisciplinary Breast Cancer Symposium 2020

Tumours were assigned to one of three pre-defined menstrual cycle windows: W1 (days 27-35 and 1-6; low E2 and low progesterone), W2 (days 7-16; high E2 and low progesterone) and W3 (days 17-26; intermediate E2 and high progesterone) based on plasma hormone measurements. ... we note anthracycline-based treatment as a potent activator of innate ... ................
................